DOUGLAS G MCNEEL, MD PHD
Osteopathic Medicine at Highland Ave, Madison, WI
License number
Wisconsin 43354
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 265-1700
(608) 266-6020 (Fax)
(608) 266-6020 (Fax)
Organization information
See more information about DOUGLAS G MCNEEL at bizstanding.comDouglas G McNeel
220 N Prospect Ave, Madison, WI 53726
Industry:
Physician - Oncologist
Douglas G Mcneel, MD
600 Highland Ave, Madison, WI 53792
Industry:
Oncology, Internist
Phone:
(608) 265-1700 (Phone)
Professional information
Prostate Cancer And Melanoma Antigens
US Patent:
2010012, May 20, 2010
Filed:
Dec 2, 2009
Appl. No.:
12/629686
Inventors:
Douglas G. McNeel - Madison WI, US
Edward J. Dunphy - Madison WI, US
Jason A. Dubovsky - Tampa FL, US
Luke H. Hoeppner - Minneapolis MN, US
Edward J. Dunphy - Madison WI, US
Jason A. Dubovsky - Tampa FL, US
Luke H. Hoeppner - Minneapolis MN, US
International Classification:
G01N 33/53
US Classification:
435 71
Abstract:
Methods for identifying a human subject as a candidate for further prostate cancer or melanoma examination are disclosed. Also disclosed are methods for determining whether an immune therapy has elicited a tumor-specific immune response in a prostate cancer or melanoma patient. Further disclosed are kits that can be used to practice the above methods. Methods for identifying candidate compounds for further testing as preventive or therapeutic agents for melanoma are also disclosed.
Prostate Cancer And Melanoma Antigens
US Patent:
7635753, Dec 22, 2009
Filed:
Feb 19, 2008
Appl. No.:
12/033229
Inventors:
Douglas G. McNeel - Madison WI, US
Edward J. Dunphy - Madison WI, US
Jason A. Dubovsky - Tampa FL, US
Luke H. Hoeppner - Minneapolis MN, US
Edward J. Dunphy - Madison WI, US
Jason A. Dubovsky - Tampa FL, US
Luke H. Hoeppner - Minneapolis MN, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
C07K 14/00
US Classification:
530350
Abstract:
Methods for identifying a human subject as a candidate for further prostate cancer or melanoma examination are disclosed. Also disclosed are methods for determining whether an immune therapy has elicited a tumor-specific immune response in a prostate cancer or melanoma patient. Further disclosed are kits that can be used to practice the above methods. Methods for identifying candidate compounds for further testing as preventive or therapeutic agents for melanoma are also disclosed.
Douglas G McNeel, Madison WI
Specialties:
Oncologist
Address:
600 Highland Ave, Madison, WI 53792
1111 Highland Ave, Madison, WI 53705
1111 Highland Ave, Madison, WI 53705
Education:
University of Chicago, Pritzker School of Medicine - Doctor of Medicine
University of Chicago - Doctor of Philosophy
University of Chicago - Doctor of Philosophy
Board certifications:
American Board of Internal Medicine Sub-certificate in Oncology (Internal Medicine)
Associate Professor Of Medicine, University Of Wisconsin-Madison
Location:
Madison, Wisconsin Area
Industry:
Research
Dr. Douglas G Mcneel, Madison WI - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
(608) 265-1700 (Phone)
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
(608) 265-1700 (Phone)
Certifications:
Internal Medicine, 1997, Medical Oncology, 2001
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS
600 Highland Ave, Madison 53792
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Richland Hospital
333 East 2 St, Richland Center 53581
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
600 Highland Ave, Madison 53792
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Richland Hospital
333 East 2 St, Richland Center 53581
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1994
University Of Wa
Graduated: 1995
Graduated: 1996
Fred Huichnson Cancer Resrch
Graduated: 1997
University Of Chicago/The Pritzker School Of Medicine
Graduated: 1994
University Of Wa
Graduated: 1995
Graduated: 1996
Fred Huichnson Cancer Resrch
Graduated: 1997
Bystander Immune Suppression As A Predictor For Response To A Vaccine
US Patent:
8603485, Dec 10, 2013
Filed:
Jan 5, 2012
Appl. No.:
13/343975
Inventors:
Douglas G. McNeel - Madison WI, US
William J. Burlingham - Madison WI, US
William J. Burlingham - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 39/00, A61K 31/713, A61K 39/395
US Classification:
4241841, 514 212, 514 44 R, 4241301
Abstract:
The present invention relates to antigen-specific immune regulatory response. Methods for detecting an antigen-specific immune regulatory response, methods for selecting candidate vaccine recipients, and methods for improved vaccination strategies are presented.
Prostate Cancer Vaccine
US Patent:
8513210, Aug 20, 2013
Filed:
Feb 21, 2011
Appl. No.:
13/031396
Inventors:
Douglas G. McNeel - Madison WI, US
Brian M. Olson - Madison WI, US
Brian M. Olson - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 48/00, C12N 15/74
US Classification:
514 44R, 4353201, 536 231
Abstract:
Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
Prostate Cancer Vaccine
US Patent:
7910565, Mar 22, 2011
Filed:
Aug 31, 2007
Appl. No.:
11/848607
Inventors:
Douglas G. McNeel - Madison WI, US
Brian M. Olson - Madison WI, US
Brian M. Olson - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 48/00
US Classification:
514 44, 4353201, 435455
Abstract:
Androgen receptor-based vaccines for eliciting an immune reaction in vivo against cells expressing androgen receptor are disclosed. The vaccines are useful in the treatment of prostate cancer. Also disclosed are methods for inducing immune reaction to androgen receptor or treating prostate cancer in a mammal, using the vaccines and pharmaceutical compositions comprising the vaccines.
Diagnostic Evaluation Of Antibody Responses To Commonly Recognized Prostate Cancer-Associated Antigens
US Patent:
2011030, Dec 8, 2011
Filed:
Apr 18, 2011
Appl. No.:
13/088594
Inventors:
Douglas G. McNeel - Madison WI, US
Brett B. Maricque - Green Bay WI, US
Brett B. Maricque - Green Bay WI, US
International Classification:
C40B 30/04, C40B 40/10
US Classification:
506 9, 506 18
Abstract:
The present invention relates to a plurality of antigens that together form a panel of immunoreactive molecules suitable for identifying candidates for prostate cancer examination. Methods for identifying antibodies indicative of a pre-malignant or malignant prostate are disclosed. Further disclosed are kits that can be used to practice the above methods.
Molecules And Methods For Treatment And Detection Of Cancer
US Patent:
2010009, Apr 15, 2010
Filed:
Nov 9, 2007
Appl. No.:
12/446953
Inventors:
Mary L. Disis - Renton WA, US
Vivian Goodell - San Diego CA, US
Hailing Lu - Seattle WA, US
Douglas G. McNeel - Madison WI, US
Vivian Goodell - San Diego CA, US
Hailing Lu - Seattle WA, US
Douglas G. McNeel - Madison WI, US
Assignee:
University of Washington - Seattle WA
International Classification:
A61K 38/18, A61K 31/7088, G01N 33/53, A61K 39/00, A61K 38/17, A61P 35/04
US Classification:
4242771, 514 12, 514 44 R, 436501, 424 9371
Abstract:
The invention provides a method for inhibiting proliferation of cancer cells, as well as methods for detecting and treating various cancers, including cancer of the ovary, breast, prostate and colon. The method comprises contacting a cancer cell with an IGF-related molecule of the invention or administering an IGF-related vaccine to the cancer patient. In one embodiment, the molecule is an immunogenic peptide derived from IGFBP-2 or from IGF1 R. The invention additionally provides methods for detecting and treating cancer using IGF-related molecules.